AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis

2018/12/18 by Cynthia W. Ko, Siddharth Singh, Joseph D. Feuerstein +27 · 26 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Inflammatory Bowel Disease #Microscopic Colitis #Helicobacter pylori-related gastroenterology studies

paper · doi:10.1053/j.gastro.2018.12.009

Citations

• Cortisone in Ulcerative Colitis
• Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases

Cited by

• Ulcerative colitis
• Ulcerative Colitis: Current and Emerging Treatment Strategies. [europepmc]
• AGA Technical Review on the Management of Moderate to Severe Ulcerative Colitis. [europepmc]
• Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases. [europepmc]
• Key Strategies to Optimize Outcomes in Mild-to-Moderate Ulcerative Colitis. [europepmc]
• The role of faecal microbiota transplantation in the treatment of inflammatory bowel disease. [europepmc]
• Capsular Polysaccharide From Bacteroides fragilis Protects Against Ulcerative Colitis in an Undegraded Form. [europepmc]
• The Role of Autophagy in Inflammatory Bowel Disease. [europepmc]
• Oral Delivery of Biologics in Inflammatory Bowel Disease Treatment. [europepmc]
• The elderly IBD patient in the modern era: changing paradigms in risk stratification and therapeutic management. [europepmc]
• Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disorders. [europepmc]
• Patient Preference and Adherence to Aminosalicylates for the Treatment of Ulcerative Colitis. [europepmc]
• The Communication Between Intestinal Microbiota and Ulcerative Colitis: An Exploration of Pathogenesis, Animal Models, and Potential Therapeutic Strategies. [europepmc]
• Inflammatory Bowel Disease Therapeutics: A Focus on Probiotic Engineering. [europepmc]
• Pulsatilla decoction alleviates colitis by enhancing autophagy and regulating PI3K‑Akt‑mTORC1 signaling pathway. [europepmc]
• Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis. [europepmc]
• Inflammatory Indexes for Assessing the Severity and Disease Progression of Ulcerative Colitis: A Single-Center Retrospective Study. [europepmc]
• An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis. [europepmc]
• Identification of useful genes from multiple microarrays for ulcerative colitis diagnosis based on machine learning methods. [europepmc]
• Selenium-enriched Bifidobacterium longum DD98 effectively ameliorates dextran sulfate sodium-induced ulcerative colitis in mice. [europepmc]
• Temperature-triggered in situ forming lipid mesophase gel for local treatment of ulcerative colitis. [europepmc]
• CD98 heavy chain as a prognostic biomarker and target for cancer treatment. [europepmc]
• The Role of the Microbiome in the Pathogenesis and Treatment of Ulcerative Colitis-A Literature Review. [europepmc]
• Genetically Engineered Microorganisms and Their Impact on Human Health. [europepmc]
• Exploring the Gut Microbiome's Role in Inflammatory Bowel Disease: Insights and Interventions. [europepmc]
• Precision microbiota therapy for IBD: premise and promise. [europepmc]